Wertentwicklung
Eckdaten
Allgemeine Fondsdaten
- ISIN
- LU1225038527
- WKN
- A2APE0
- Währung
- Euro
- Ausschüttungsart
- Thesaurierend
- Steuerklasse
- blütenweißer Fonds
- Fondsvolumen
- 38.55 Mio. USD
- Auflagedatum
- 19.06.2015
- Geschäftsjahresbeginn
- 1. January
- KAG
- AZ Fund Management SA
- Domizil
- Luxemburg
- Depotbank
- BNP Paribas, Luxembourg Branch
- Fondsmanager
- Saverio Papagno, Marco Fazi
Fokus, Kosten und Bewertung
- Kategorie
- Alternative Investments, Hedgefonds Single Strategie
- Region
- Global
- Laufende Kosten
- 3,50%
- Transaktionskosten
- 0,40%
- Performancegebühr
- 20%
- Managementgebühr
- 1,35%
- Maximaler Ausgabeaufschlag
- 2%
- Rücknahmegebühr
- 0%
- Mindestkaufvolumen
- € 1.500,00
- Risiko-Ertrags-Profil
- SRI 2
- Nachhaltigkeit SFDR
- Artikel-6-Fonds
The Sub-fund's investment objective is to achieve medium-term capital growth. The Sub-fund is actively managed and aims to deliver positive absolute returns on the basis of a merger arbitrage strategy that entails gaining exposure to companies involved in extraordinary corporate finance transactions that have already been publicly announced (primarily mergers and acquisitions, but also spinoffs and any other forms of corporate restructuring) or that market participants know to be possible (through coverage in the media and/or specialised economic information sources).
So wird investiert
Anlageklassen
Länder
Branchen
Laufzeiten
Top-Ten Titel
- US TREASURY BILL 0% 22-30/11/2023
- 22,40%
- US TREASURY BILL 0% 22-28/12/2023
- 11,20%
- HELIUM FUND-HELIUM SEL-A USD
- 8,10%
- ACTIVISION BLIZZARD INC
- 6,40%
- FORGEROCK INC-A
- 5,80%
- BELLUS HEALTH INC
- 5,00%
- TOWER SEMICONDUCTOR LTD
- 4,50%
- SEAGEN INC
- 4,50%
- CTI BIOPHARMA CORP
- 4,20%
- HORIZON THERAPEUTICS PLC
- 3,70%
